← 產業報告目錄
Weight Loss Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Prescription and Over-the-counter), By Application (Appetite Suppression, Fat Blocking, and Others)), By Distribution Channel, By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-18頁數 180報告編號 INSIGHTACE-4518dd4288
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Weight Loss Drugs Market worldwide was assessed at USD 26.3 billion. Analysts project it will surge to USD 108.9 billion by 2031, at a CAGR of 19.7% spanning 2024 to 2031.
The Weight Loss Drugs sector involves The weight loss drugs market is witnessing meaningful growth due to the global rise in obesity rates and related health concerns. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is bolstered by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Weight Loss Drugs Market Snapshot
Chapter 4. Global Weight Loss Drugs Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Drug Type Estimates & Trend Analysis
5.1. by Drug Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Drug Type:
5.2.1. Prescription
5.2.2. Over-the-counter
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Appetite Suppression
6.2.2. Fat Blocking
6.2.3. Others
Chapter 7. Weight Loss Drugs Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2019-2031
7.1.2. North America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.1.3. North America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2019-2031
7.2.2. Europe Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.2.3. Europe Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2019-2031
7.3.2. Asia-Pacific Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.3.3. Asia Pacific Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2019-2031
7.4.2. Latin America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.4.3. Latin America Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2019-2031
7.5.2. Middle East & Africa Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.5.3. Middle East & Africa Weight Loss Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Novo Nordisk A/S
8.2.2. Eli Lilly & Co.
8.2.3. Amgen Inc.
8.2.4. Pfizer Inc.
8.2.5. Viking Therapeutics Inc.
8.2.6. Structure Therapeutics Inc.
8.2.7. F. Hoffmann-La Roche Ltd
8.2.8. Teva Pharmaceutical Industries Ltd
8.2.9. GlaxoSmithKline plc
8.2.10. Sandoz International GmbH
8.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們